Want to see USPH full AI Analyst Report?
USPH Stock Chart & Stats
$76.57
$0.25(0.28%)
At close: 4:00 PM EST
$76.57
$0.25(0.28%)
Day’s Range― - ―
52-Week Range$58.19 - $93.50
Previous CloseN/A
Volume11.83K
Average Volume (3M)211.80K
Market Cap
$1.12B
Enterprise Value$1.29B
Total Cash (Recent Filing)$28.44M
Total Debt (Recent Filing)$362.83M
Price to Earnings (P/E)143.6
Beta0.95
Next Earnings
Jul 30, 2026EPS Estimate
0.81Next Dividend Ex-DateN/A
Dividend Yield2.25%
Share Statistics
EPS (TTM)0.50
Shares Outstanding15,218,789
10 Day Avg. Volume243,741
30 Day Avg. Volume211,797
Financial Highlights & Ratios
PEG Ratio-2.41
Price to Book (P/B)2.49
Price to Sales (P/S)1.52
P/FCF Ratio19.43
Enterprise Value/Market Cap1.16
Enterprise Value/Revenue1.77
Enterprise Value/Gross Profit8.66
Enterprise Value/Ebitda12.47
Forecast
1Y Price Target
$92.67Price Target Upside21.02% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)2.9
Revenue Forecast (FY)$838.68M
Bulls Say, Bears Say
Bulls Say
Revenue & Cash GenerationSustained multi-year revenue growth alongside positive operating cash flow (~$84M TTM) and free cash flow (~$67M TTM) creates durable internal funding for reinvestment, M&A and dividends. Strong cash generation lowers reliance on external financing and supports execution over the next 2–6 months.
IIP Segment MomentumThe industrial injury prevention (IIP) business is growing faster with margin expansion to 20.4%, providing higher‑margin diversification versus core outpatient PT. Durable employer contracts and improving same‑store IIP trends can sustainably lift consolidated margins and reduce dependence on referral cycles.
Improved Financial FlexibilityA new five‑year $450M credit facility extends maturities, improves cost of capital and preserves capacity for acquisitions and partnership investments. This structural boost to liquidity supports strategic rollouts and hospital alliances without immediate refinancing pressure, aiding medium-term growth plans.
Bears Say
Compressed ProfitabilityNet margin and ROE have fallen sharply (net margin ~1.5%, ROE ~2%), indicating earnings are not scaling with revenue. Persistent margin compression reduces retained earnings and capital efficiency, limiting capacity to fund growth or weather shocks without further cost control or higher rate capture.
Rising Operating CostsIncreasing payroll and operating cost per visit have eroded adjusted PT margins (down ~70 bps). Structural labor market pressures, contract labor use and higher overhead can persist, pressuring unit economics and requiring sustained productivity gains or pricing power to restore historical margins.
Leverage & Cash DeclineAcquisitions and noncontrolling interest purchases increased borrowings and reduced cash balances, tightening liquidity. Although leverage has improved versus earlier peaks, fluctuating debt and lower cash buffers heighten sensitivity to earnings shocks and interest costs, constraining financial flexibility if margins remain compressed.
US Physical Therapy News
USPH FAQ
What was U.s. Physical Therapy’s price range in the past 12 months?
U.s. Physical Therapy lowest stock price was $58.19 and its highest was $93.50 in the past 12 months.
What is U.s. Physical Therapy’s market cap?
U.s. Physical Therapy’s market cap is $1.12B.
When is U.s. Physical Therapy’s upcoming earnings report date?
U.s. Physical Therapy’s upcoming earnings report date is Jul 30, 2026 which is in 21 days.
How were U.s. Physical Therapy’s earnings last quarter?
U.s. Physical Therapy released its earnings results on May 06, 2026. The company reported $0.46 earnings per share for the quarter, missing the consensus estimate of $0.517 by -$0.057.
Is U.s. Physical Therapy overvalued?
According to Wall Street analysts U.s. Physical Therapy’s price is currently Undervalued.
Does U.s. Physical Therapy pay dividends?
U.s. Physical Therapy pays a Quarterly dividend of $0.46 which represents an annual dividend yield of 2.25%. See more information on U.s. Physical Therapy dividends here
What is U.s. Physical Therapy’s EPS estimate?
U.s. Physical Therapy’s EPS estimate is 0.81.
How many shares outstanding does U.s. Physical Therapy have?
U.s. Physical Therapy has 15,218,789 shares outstanding.
What happened to U.s. Physical Therapy’s price movement after its last earnings report?
U.s. Physical Therapy reported an EPS of $0.46 in its last earnings report, missing expectations of $0.517. Following the earnings report the stock price went down -19.891%.
Which hedge fund is a major shareholder of U.s. Physical Therapy?
Currently, no hedge funds are holding shares in USPH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
US Physical Therapy Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$92.67 (21.02% Upside)
$92.67 (21.02% Upside)
Blogger Sentiment
Bearish
USPH Sentiment 70%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 132.8K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.2%
Last 30 Days ▲ 2.1%
Last 30 Days ▲ 2.1%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-8.41%
12-Months-Change
Fundamentals
Return on Equity
0.24%
Trailing 12-Months
Asset Growth
5.29%
Trailing 12-Months
Company Description
U.s. Physical Therapy
U.S. Physical Therapy, Inc., through its various subsidiaries, manages a network of outpatient physical therapy facilities. These clinics deliver a range of services, including rehabilitation before and after surgery, treatment for musculoskeletal conditions, recovery from sports-related trauma, proactive health measures, assistance for workers recovering from injuries, and care for neurological conditions. The company's business is divided into two primary divisions: Physical Therapy Operations and Industrial Injury Prevention Services. Within its industrial segment, it provides specialized services like on-site injury avoidance and recovery programs, strategies for enhancing physical performance, pre-employment screening tests, assessments of an individual's work capacity, and workplace ergonomic reviews. These offerings are delivered by licensed physical therapists and expert certified athletic trainers to a diverse clientele, including Fortune 500 corporations, insurance providers, and their associated contractors. By the end of 2021, specifically December 31st, the company had established 591 operational clinics across 39 states, in addition to overseeing 35 other physical therapy sites. Established in 1990, the company maintains its headquarters in Houston, Texas.
USPH Company Deck
USPH Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call communicated solid top-line growth, strengthening visit trends, and strategic progress (IIP margin expansion, hospital affiliations starting, expanded credit facility and targeted technology/ cash-program rollouts). Near-term pressures—weather-related lost visits, higher operating and corporate costs, elevated tax rate, and GAAP per-share impacts from revaluations—temporarily weighed on margins and net income. Management affirmed full-year adjusted EBITDA guidance, highlighted recoveries as seasonality normalizes and hospital ramps accelerate, and presented confidence in execution of strategic initiatives.View all USPH earnings summariesUSPH Stock 12 Month Forecast
Average Price Target
$92.67
▲(21.02% Upside)
Technical Analysis
AMN Healthcare Services
―
Healthcare Services
―
Pediatrix Medical Group
―
Select Medical
―
Pennant Group
―
Ownership Overview
2.31% Insiders
29.05% Mutual Funds
5.63% Other Institutional Investors
36.59% Public Companies and
Individual Investors